References:
[1] R.L. Siegel, K.D. Miller, A. Jemal, Cancer statistics for Hispanics/Latinos, 2015, CA: a cancer journal for clinicians. 65(2015), 5-29.
[2] J. Verma, B.J. Monk, A.H. Wolfson, New strategies for multi-modality therapy in treating locally advanced cervix cancer, Semin Radiat Oncol. 26(2016), 344-348.
[3] F.X. Bosch, M.M. Manos, Prevalence of human papillomavirus in cervical cancer: A worldwide perspective, J Natl Cancer Inst. 87(1995), 796-802.
[4] S. Fujiwara, N. Takeo, Y. Otani, et al, Epiplakin, a novel member of the Plakin family originally identified as a 450-kDa human epidermal autoantigen, J Biol Chem. 276(2001), 13340-13347.
[5] N. Takeo, W. Wang, N. Matsuo, et al, Structure and heterogeneity of the human gene for epiplakin (EPPK1), J Invest Dermatol. 121(2003), 1224-1236.
[6] B. Blagoev, I. Kratchmarova, S.E. Ong, et al, A proteomics strategy to elucidate functional protein-protein interactions applied to EGF signaling, Nat Biotechnol. 21(2003), 315-318.
[7] T. Shen, Y. Lu, Q. Zhang, High squalene epoxidase in tumors predicts worse survival in patients with hepatocellular carcinoma: integrated bioinformatic analysis on NAFLD and HCC, Cancer Control. 27(2020), 1-9.
[8] H. Lee, K. Kim, J. Woo, et al, Quantitative proteomic analysis identifies AHNAK (neuroblast differentiation-associated protein AHNAK) as a novel candidate biomarker for bladder urothelial carcinoma diagnosis by liquid-based cytology, Mol Cell Proteomics. 17(2018), 1788-1802.
[9] X. Guo, Y. Hao, M. Kamilijiang, et al, Potential predictive plasma biomarkers for cervical cancer by 2D-DIGE proteomics and Ingenuity Pathway Analysis, Tumor Biol. 36(2014), 1711-1720.
[10] A. Smith, L. Poole, K. Dhanwada, et al, Identification of candidate biomarkers and cancer genes AHNAK2 and EPPK1 in pancreatic cancer, BJMMR. 18(2016), 2231-0614.
[11] J.T. Dong, C. Chen, Essential role of KLF5 transcription factor in cell proliferation and differentiation and its implications for human diseases, Cell Mol Life Sci. 66(2009), 2691-2706.
[12] D. Ma, L.Y. Chang , S. Zhao , et al, KLF5 promotes cervical cancer proliferation, migration and invasion in a manner partly dependent on TNFRSF11a expression, Sci Rep. 7(2017), 15683.
[13] J.H. Shi, B. Zheng, S. Chen, et al, Retinoic acid receptor α mediates all-trans-retinoic acid-induced Klf4 gene expression by regulating klf4 promoter activity in vascular smooth muscle cells, J Biol Chem. 287(2012), 10799-10811.
[14] E. Ortega, J.A. Manso, R.M. Buey, et al, The structure of the plakin domain of plectin reveals an extended rod-like shape, J Biol Chem. 291(2016), 18643-18662.
[15] D. Sawamura, K. Li, M.L. Chu, et al, Human bullous pemphigoid antigen (BPAG1). Amino acid sequences deduced from cloned cDNAs predict biologically important peptide segments and protein domains, J Biol Chem. 266(1991), 17784-17790.
[16] T. Yoshida, N. Shiraki, H. Baba, et al, Expression patterns of epiplakin1 in pancreas, pancreatic cancer and regenerating pancreas, Genes Cells. 13(2018), 667-678.
[17] R.F. Dunne, A.F. Hezel, Genetics and biology of pancreatic ductal adenocarcinoma, Genes Dev. 29(2015), 595-608.
[18] D. Marrero-Rodrgíuez, K. Taniguchi-Ponciano, F. Jimenez-Vega, et al, Krüppel-like factor 5 as potential molecular marker in cervical cancer and the KLF family profile expression, Tumor Biol. 35(2014), 11399-11407.
[19] R.I. Nicholson, J.M. Gee, M.E. Harper, EGFR and cancer prognosis, Eur J Cancer. 37(2001), S9-15.
[20] F. Ciardiello, A novel approach in the treatment of cancer: targeting the epidermal growth factor receptor, Clin Cancer Res. 7 (2001), 2958-2970.
[21] A.M. Ohm, T. Affandi, M.E. Reyland, EGF receptor and PKCδ kinase activate DNA damage-induced pro-survival and pro-apoptotic signaling via biphasic activation of ERK and MSK1 kinases, J Biol Chem. 294(2019), 4488-4497.
[22] Z.B. Xie, Y.F. Zhang, C. Jin, et al, LRG-1 promotes pancreatic cancer growth and metastasis via modulation of the EGFR/p38 signaling, J Exp Clin Cancer Res. 38(2019), 75.
[23] Q. Cao, N. Wang, L. Ren, et al, MiR-125a-5p post-transcriptionally suppresses GALNT7 to inhibit proliferation and invasion in cervical cancer cells via the EGFR/PI3K/AKT pathway, Cancer Cell Int. 20(2020), 117.
[24] B.B. McConnell, V.W. Yang, Mammalian Krüppel-like factors in health and diseases, Physiol Rev. 90(2010), 1337-1381.
[25] M.O. Nandan, H.S. Yoon, W. Zhao, et al, Krüppel-like factor 5 mediates the transfecting activity of oncogenic H-Ras, Oncogene. 23(2014), 3404-3413.
[26] Y. Yang, B.G. Goldstein, H. Nakagawa, et al, Krüppel-like factor 5 activates MEK/ERK signaling via EGFR in primary squamous epithelial cells, FASEB J. 21(2007), 543-550.
[27] A. Matsuo, T. Yoshida, T. Yasukawa, et al, Epiplakin1 is expressed in the cholangiocyte lineage cells in normal liver and adult progenitor cells in injured liver, Gene Expr Patterns. 11(2011), 255-262.
[28] B. Lagoev, I. Kratchmarova, S.E. Ong, et al, A proteomics strategy to elucidate functional protein-protein interactions applied to EGF signaling, Nat Biotechnol. 21(2003), 315-318.